Sell In data allows manufacturers to conduct market audits, analyze the dynamics of their brands and competitors, predict the success of new drug launches, and develop effective strategies for business growth.
Speed monthly on the 12th day, every ten days - on the 6th day
#1 in Kazakhstan
Accuracy more than 91% market
No. 1 in the EAEU
Geography – Country/Regions/Cities
Coverage – more than 8000 active pharmacies
It is important for manufacturers to have data for the entire market, not just from contracted distributors. Distributor reports only cover shipments of their own drugs, which is insufficient for strategic planning and business scaling
Sell In analysis will help the manufacturer understand the movement of the drug and answer questions:
Where my products are in greater demand
Has the price increase affected consumption?
How does sickness or allergy season affect my sales?
Which distributor sells more?
How external circumstances affect pharmacy procurement
Is Launching Marketing Activity Effective?
The LPU Tender data provide manufacturers with a valuable basis for auditing the state supply market at the level of health care institutions (HCI). They allow them to analyze the dynamics of their brands and competitors, forecast the potential for launching new drugs, and build effective strategies for business development.
#1 in Kazakhstan
Database of operating healthcare facilities in Kazakhstan
Sell In — customizable analytical system report base.viortis, based on pharmacy purchase data from distributors. The report covers pharmacy orders for all product names.
Data sources
● 5 currencies: tenge, dollar, euro, ruble, pound sterling
● Competitors price analysis min/max
● NFC - New Form Classification
+7 747 094 1177
+7 474 094 11 10
+7 747 094 11 00